Morphoceuticals Raises $8 Million To Advance Electroceutical Approach To Regenerative Medicine
02/15/23, 2:04 PM
Location
medfordMoney raised
$8 million
Industry
biotechnology
Investors
Juvenescence, Prime Movers Lab
Morphoceuticals Inc., a biotechnology company, announced it closed an $8 million Seed-2 funding round led by Prime Movers Lab and initial investor Juvenescence. Morphoceuticals is pioneering the use of artificial intelligence-guided electroceuticals to regenerate limbs, repair tissues, and regenerate organs, leveraging the groundbreaking work of Professors Michael Levin and David Kaplan from Tufts University.
Company Info
Location
medford, massachusetts, united states
Additional Info
Morphoceuticals is a new biotech company creating the first map of the druggable bioelectrome. By using multi-omics, bioelectric profiling and AI, we aim to exploit the electrical network controlling tissue repair and organ regeneration that exists throughout our bodies.